Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil
- Written by PR Newswire
![]() |
- "Aiming to offer a Dengue antiviral treatment course in $100 price range"
- Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval
SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced on April 25th that, after multiple...
Read more: Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil















